9060 POSTER Phase I Trial of Pemetrexed and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Japanese Patients With Locally Advanced Non-Small-Cell Lung Cancer
Ikuo Sekine(University of Tsukuba), Tomohide Tamura(St. Luke's International Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Keiji Nihei(Osaka Medical and Pharmaceutical University), Seiji Niho(Dokkyo Medical University), Jumpei Funai(Eli Lilly (Japan)), Yuichiro Ohe(National Cancer Center), Kayoko Kubota, R. Sekiguchi, Sotaro Enatsu(Eli Lilly (Japan))
Cited by 0
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2017|1.2k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749